Trial Comparing Two Commercial Formulations of Botulinum Toxin Type A in the Treatment of Spasticity

NCT00819065 ↗

Phase 3 Completed 56 enrolled Hospital de Clinicas de Porto Alegre

RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to compare the effectiveness between two commercial formulations of botulinum toxin type A in the treatment of spasticity through the Ashworth scale.

Timeline

Start: 2009-03
Primary completion: 2010-05
Completion: 2011-06

Publications

Guarany FC, Picon PD, Guarany NR, dos Santos AC, Chiella BP, Barone CR, Fendt LC, Schestatsky P. A double-blind, randomised, crossover trial of two botulinum toxin type a in patients with spasticity. PLoS One. 2013;8(2):e56479. doi: 10.1371/journal.pone.0056479. Epub 2013 Feb 28.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Botulinum toxin type A	Protein / enzyme biologic	—	—

Indications

No indication recorded.